stockrow
Friday 6 November 2026
Export PRVA’s income statement to Excel — free account
Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
24.32
0.38
+1.59%
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Total debt
Privia Health Group, Inc.'s total debt at the end of fiscal 2022 was $8.5M, down 73.2% from $31.7M in fiscal 2021. At the end of the quarter to 30 September 2023 it was $5.8M. Privia Health Group, Inc. ranks 34th of 42 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $8.5M | (73.21%) |
| FY2021 | $31.7M | (3.34%) |
| FY2020 | $32.8M | (17.47%) |
| FY2019 | $39.7M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $5.8M | (11.37%) |
| Jun 2023 | $6.5M | (16.44%) |
| Mar 2023 | $7.8M | (8.27%) |
| Dec 2022 | $8.5M | (7.60%) |
| 8 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| WAY Waystar Holding Corp. compare | $1.5B |
| TDOC Teladoc Health, Inc. compare | $997.6M |
| GDRX GoodRx Holdings, Inc. compare | $486.6M |
| CERT Certara, Inc. compare | $291.2M |
| HTFL Heartflow, Inc. compare | $182.4M |
| OMCL Omnicell, Inc. compare | $168.5M |
| SDGR Schrodinger, Inc. compare | $129.0M |
| DOCS Doximity, Inc. compare | $15.0M |
| PRVA Privia Health Group, Inc. | $5.8M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement